• Place it Directly Under Your Tongue: Placing CBD isolate powder directly under your tongue is, by far, the easiest way to use isolate. Hold it there for about 60 seconds. The CBD will then be delivered to the bloodstream via the mucus membranes to provide the relief you desire. CBD has no taste or odor so this shouldn’t be too uncomfortable of an experience.
Because it does not produce psychoactive effects and hemp is not a controlled substance, hemp-based products are legal to sell, buy, and possess in all 50 states. However, the law is a bit more complex when discussing CBD oils and other hemp byproducts. According to the 2014 Farm Bill, hemp should only be grown and cultivated for academic research purposes. This means that, technically, any hemp-derived oil that is not grown for these purposes would be illegal — though this law is rarely enforced. To make matters more complex, the laws are somewhat unclear in certain states. Sen. Mitch McConnell of Kentucky recently introduced legislation that would legalize all hemp products at the federal level, but this decision is still pending.
THC is one of the cannabinoids involved in the "entourage effect" stated earlier so it is ideal for inclusion in CBD supplementation. A recent article on full-spectrum CBD demonstrates the importance of THC inclusion by stating, "In hemp THC is a minor constituent and appears only in trace amounts under 0.3% by dry weight, as required by the U.S. government for hemp products. THC mimics the action of anandamide, a neurotransmitter naturally produced in the human body, and binds to CB1 receptors in the endocannabinoid system found mostly in the brain. The extremely low levels of THC in hemp make hemp oil non-psychoactive and safe for all ages to use."
Jump up ^ Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu AX, Fujioka M, Abe K, Hasebe N, Egashira N, Iwasaki K, Fujiwara M (March 2007). "Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance". Neuropharmacology. 52 (4): 1079–87. doi:10.1016/j.neuropharm.2006.11.005. PMID 17320118.